CAS: 1004757-96-3
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide REF: 3D-EQB75796CAS: 1004757-96-3 | Min. 95% | Prezzo su richiesta | Mar 21 Gen 25 | |
BMS-741672 REF: TM-T71640CAS: 1004757-96-3 | - - - | 2.890,00 €~5.288,00 € | Lun 10 Mar 25 |
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide
CAS:1004757-96-3
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide (NAPQI) is a new drug that is being developed for the treatment of autoimmune …
Formula:
C25H33F3N6O2
Purezza:
Min. 95%
Peso molecolare:
506.6 g/mol
Ref: 3D-EQB75796
100mg | Prezzo su richiesta | ||
250mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
BMS-741672
CAS:1004757-96-3
BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.
Formula:
C25H33F3N6O2
Colore e forma:
Liquid
Peso molecolare:
506.56
Ref: TM-T71640
25mg | 2.890,00 € | ||
50mg | 3.811,00 € | ||
100mg | 5.288,00 € |
Consegna stimata in Stati Uniti, il Lunedì 10 Marzo 2025